Skip to content

Glenmark pharma share price moneycontrol

23.10.2020
Wedo48956

MoneyControl; Feb 14, 2020 10:46. © Reuters. sizes= Glenmark Pharma sells gynaecology business, share price gains. The share touched its 52-week high  Glenmark inks licensing pact with Hikma for commercialisation of nasal spray Ryaltris in US. Moneycontrol. The licensing pact for Ryaltris has been signed  Why GLENMARK shares are falling or up today? Glenmark Pharmaceuticals Ltd. You can also check GLENMARK share price target recommended by brokerages. https://www.moneycontrol.com/news/business/markets/broker reply. For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 368.90 this results in a dividend yield of 0.54%.

Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019.

MoneyControl; Feb 14, 2020 10:46. © Reuters. sizes= Glenmark Pharma sells gynaecology business, share price gains. The share touched its 52-week high  Glenmark inks licensing pact with Hikma for commercialisation of nasal spray Ryaltris in US. Moneycontrol. The licensing pact for Ryaltris has been signed  Why GLENMARK shares are falling or up today? Glenmark Pharmaceuticals Ltd. You can also check GLENMARK share price target recommended by brokerages. https://www.moneycontrol.com/news/business/markets/broker reply. For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 368.90 this results in a dividend yield of 0.54%.

Get Live BSE/ NSE share price of Glenmark Pharma. View Glenmark Pharma historical charts, stock market reports, financial report, volume, market performance & latest news on NDTV Profit.

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. GLENMARK PHARMA: Get the latest GLENMARK PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com Share market update: BSE Midcap index dips; Glenmark Pharma slumps 5% The S&P BSE MidCap index was trading 0.89 per cent down at 15,554.74.

Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019.

Glenmark Pharmaceuticals Ltd Stock Price (209.60) - Check here Glenmark Pharmaceuticals Ltd share price today live, Glenmark Pharmaceuticals Ltd stock price, Glenmark Pharmaceuticals Ltd NSE/BSE Glenmark Pharmaceuticals Limited Stock Trends in 2016 and 2017. At the start of 2016, the share price of Glenmark Pharmaceuticals was at levels around Rs.930. In roughly three weeks, the stock lost a little over 10% to descend into the Rs.700 region. Through most of February, the shares were traded at levels varying from Rs.710 - Rs.750. Glenmark Pharmaceuticals Ltd Stock/Share prices, Live BSE/NSE, F&O Quote of Glenmark Pharmaceuticals Ltd. with Historic price charts for NSE / BSE. detailed news, announcements, financial report, company information, annual report, balance sheet, profit & loss account, results and more. Glenmark Pharmaceuticals Live NSE/BSE Share Price: Get Glenmark Pharmaceuticals Stock Price details, News, Financial Results, Stock Charts, Returns, Research Reports and more By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.

For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 368.90 this results in a dividend yield of 0.54%.

For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 368.90 this results in a dividend yield of 0.54%. Get Live Glenmark Pharma stock market chart. Free Glenmark Historic stock charts for NSE / BSE. Get Glenmark Pharma detailed stock quotes and technical charts for Glenmark. Moneycontrol Technical Chart Analysis of Glenmark, BSE/NSE Market chart analysis,live market index & techical information with graph in advance features.

real time apple stock price - Proudly Powered by WordPress
Theme by Grace Themes